13 May 2024 - In this cross-sectional study of 1429 patents and patent applications protecting the 10 highest revenue brand name drugs in the US in 2021, almost three-quarters were filed after US FDA approval. 

Patents filed after FDA approval and those protecting parts of the drug other than the active ingredient contributed to dense patent thickets.

Read JAMA Internal Medicine article